Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neurosurgery Devices Market by Product (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid (CSF) Management Devices, Others) , by Application (Spinal Cord Stimulation, Deep Brain Stimulation, Neuroendoscopy) by End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A06255

Pages: 280

Charts: 61

Tables: 138

Neurosurgery Devices Market Research, 2033

Market Introduction and Definition

The global neurosurgery devices market size was valued at $11.9 billion in 2023, and is projected to reach $34.5 billion by 2033, growing at a CAGR of 11.3% from 2024 to 2033. The growth of the neurosurgery devices market is driven by several key factors, including the increasing prevalence of neurological disorders such as brain tumors, Parkinson's disease, and epilepsy. Technological advancements in minimally invasive surgical techniques and the development of innovative neurosurgical devices also contribute to market expansion. Additionally, the rising demand for precision and safety in complex neurosurgical procedures, along with increased healthcare expenditure and better access to healthcare services in emerging economies, further fuels the market's growth. Neurosurgery devices are specialized tools and instruments used in surgical procedures involving the brain, spinal cord, and peripheral nerves. These devices play a critical role in diagnosing, treating, and managing various neurological conditions, such as brain tumors, aneurysms, spinal disorders, and traumatic brain injuries. The range of neurosurgery devices includes neuroendoscopes, neuromodulation devices, stereotactic systems, and cerebrospinal fluid management devices, among others. Their applications are vast, encompassing minimally invasive surgeries, deep brain stimulation, and the precise removal of brain tumors. The advancements in these devices have significantly improved the precision, safety, and outcomes of neurosurgical procedures, which enable better patient recovery and reduce the risks associated with complex neurological surgeries.

Key Takeaways 

  • The Neurosurgery Devices market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major Neurosurgery Devices industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Product
    • Neurostimulation Devices
    • Neurointerventional Devices
    • Neurosurgical Navigation Systems
    • Cerebral Spinal Fluid (CSF) Management Devices
    • Others
  • By Application
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Neuroendoscopy
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Ackermann Instrumente GmbH
  • Johnson and Johnson
  • Biotronik SE & Co. KG
  • Medtronic plc
  • Adeor Medical AG
  • Stryker Corporation.
  • Integra Lifesciences Corporation.
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Boston Scientific Corporation

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NEUROSURGERY DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Neurostimulation Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Neurointerventional Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Neurosurgical Navigation Systems

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Cerebral Spinal Fluid (CSF) Management Devices

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROSURGERY DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Spinal Cord Stimulation

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Deep Brain Stimulation

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Neuroendoscopy

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROSURGERY DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROSURGERY DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Neurosurgery Devices Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Neurosurgery Devices Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Neurosurgery Devices Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Neurosurgery Devices Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Neurosurgery Devices Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Neurosurgery Devices Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Neurosurgery Devices Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Neurosurgery Devices Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Neurosurgery Devices Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Neurosurgery Devices Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Neurosurgery Devices Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Neurosurgery Devices Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Neurosurgery Devices Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Neurosurgery Devices Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Neurosurgery Devices Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Neurosurgery Devices Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Neurosurgery Devices Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Neurosurgery Devices Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Neurosurgery Devices Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Neurosurgery Devices Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Neurosurgery Devices Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Neurosurgery Devices Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Neurosurgery Devices Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Neurosurgery Devices Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Neurosurgery Devices Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Abbott Laboratories

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Ackermann Instrumente GmbH

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Adeor Medical AG

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. B. Braun Melsungen AG

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Biotronik SE And Co. KG

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Boston Scientific Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Johnson And Johnson

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Integra Lifesciences Corporation.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Medtronic Plc

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Stryker Corporation.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEUROINTERVENTIONAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEUROSURGICAL NAVIGATION SYSTEMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY DEVICES MARKET FOR CEREBRAL SPINAL FLUID (CSF) MANAGEMENT DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA NEUROSURGERY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. U.S. NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. U.S. NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. U.S. NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. CANADA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. CANADA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. CANADA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE NEUROSURGERY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. ITALY NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. ITALY NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. ITALY NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. UK NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. UK NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. UK NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC NEUROSURGERY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. CHINA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. CHINA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. CHINA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. INDIA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. INDIA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. INDIA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA NEUROSURGERY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 98. UAE NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 99. UAE NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. UAE NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA NEUROSURGERY DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA NEUROSURGERY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA NEUROSURGERY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 107. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 108. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 109. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 110. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 111. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. ACKERMANN INSTRUMENTE GMBH: KEY EXECUTIVES
  • TABLE 113. ACKERMANN INSTRUMENTE GMBH: COMPANY SNAPSHOT
  • TABLE 114. ACKERMANN INSTRUMENTE GMBH: OPERATING SEGMENTS
  • TABLE 115. ACKERMANN INSTRUMENTE GMBH: PRODUCT PORTFOLIO
  • TABLE 116. ACKERMANN INSTRUMENTE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ADEOR MEDICAL AG: KEY EXECUTIVES
  • TABLE 118. ADEOR MEDICAL AG: COMPANY SNAPSHOT
  • TABLE 119. ADEOR MEDICAL AG: OPERATING SEGMENTS
  • TABLE 120. ADEOR MEDICAL AG: PRODUCT PORTFOLIO
  • TABLE 121. ADEOR MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 124. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 126. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
  • TABLE 128. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
  • TABLE 129. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
  • TABLE 130. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 131. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 133. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 134. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 135. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 138. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 139. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 140. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 141. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. INTEGRA LIFESCIENCES CORPORATION.: KEY EXECUTIVES
  • TABLE 143. INTEGRA LIFESCIENCES CORPORATION.: COMPANY SNAPSHOT
  • TABLE 144. INTEGRA LIFESCIENCES CORPORATION.: OPERATING SEGMENTS
  • TABLE 145. INTEGRA LIFESCIENCES CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 146. INTEGRA LIFESCIENCES CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 148. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 149. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 150. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 151. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. STRYKER CORPORATION.: KEY EXECUTIVES
  • TABLE 153. STRYKER CORPORATION.: COMPANY SNAPSHOT
  • TABLE 154. STRYKER CORPORATION.: OPERATING SEGMENTS
  • TABLE 155. STRYKER CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 156. STRYKER CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET
  • FIGURE 3. SEGMENTATION NEUROSURGERY DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROSURGERY DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROSURGERY DEVICES MARKET
  • FIGURE 11. NEUROSURGERY DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NEUROSURGERY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NEUROSURGERY DEVICES MARKET FOR NEUROINTERVENTIONAL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NEUROSURGERY DEVICES MARKET FOR NEUROSURGICAL NAVIGATION SYSTEMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. NEUROSURGERY DEVICES MARKET FOR CEREBRAL SPINAL FLUID (CSF) MANAGEMENT DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. NEUROSURGERY DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. NEUROSURGERY DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: NEUROSURGERY DEVICES MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. ACKERMANN INSTRUMENTE GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. ACKERMANN INSTRUMENTE GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. ACKERMANN INSTRUMENTE GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. ADEOR MEDICAL AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ADEOR MEDICAL AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ADEOR MEDICAL AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. BIOTRONIK SE AND CO. KG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. INTEGRA LIFESCIENCES CORPORATION.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. STRYKER CORPORATION.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. STRYKER CORPORATION.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. STRYKER CORPORATION.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Neurosurgery Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved